180 related articles for article (PubMed ID: 30225261)
1. Dynamic Three-Dimensional Contrast-Enhanced Ultrasound to Predict Therapeutic Response of Radiofrequency Ablation in Hepatocellular Carcinoma: Preliminary Findings.
Cao J; Dong Y; Mao F; Wang W
Biomed Res Int; 2018; 2018():6469703. PubMed ID: 30225261
[TBL] [Abstract][Full Text] [Related]
2. 3D versus 2D contrast-enhanced sonography in the evaluation of therapeutic response of hepatocellular carcinoma after locoregional therapies: preliminary findings.
Bartolotta TV; Taibbi A; Matranga D; Midiri M; Lagalla R
Radiol Med; 2015 Aug; 120(8):695-704. PubMed ID: 25698299
[TBL] [Abstract][Full Text] [Related]
3. [Application value of real-time three-dimensional contrast-enhanced ultrasound for morphological assessing of hepatocellular carcinoma before radiofrequency ablation treatment].
Wang XC; Li SY; Fang Y; Zhou L; Xu LL; Wu Y
Zhonghua Zhong Liu Za Zhi; 2018 Mar; 40(3):217-221. PubMed ID: 29575843
[No Abstract] [Full Text] [Related]
4. 3D fusion is superior to 2D point-to-point contrast-enhanced US to evaluate the ablative margin after RFA for hepatocellular carcinoma.
Long H; Zhou X; Zhang X; Ye J; Huang T; Cong L; Xie X; Huang G
Eur Radiol; 2024 Feb; 34(2):1247-1257. PubMed ID: 37572191
[TBL] [Abstract][Full Text] [Related]
5. Clinical value of dynamic 3-dimensional contrast-enhanced ultrasound imaging for the assessment of hepatocellular carcinoma ablation.
Wang Y; Jing X; Ding J
Clin Imaging; 2016; 40(3):402-6. PubMed ID: 27133676
[TBL] [Abstract][Full Text] [Related]
6. Irreversible electroporation of hepatocellular carcinoma: preliminary report on the diagnostic accuracy of magnetic resonance, computer tomography, and contrast-enhanced ultrasound in evaluation of the ablated area.
Granata V; de Lutio di Castelguidone E; Fusco R; Catalano O; Piccirillo M; Palaia R; Izzo F; Gallipoli AD; Petrillo A
Radiol Med; 2016 Feb; 121(2):122-31. PubMed ID: 26345332
[TBL] [Abstract][Full Text] [Related]
7. Contrast-enhanced ultrasound improves real-time imaging of ablation region during radiofrequency ablation: preliminary results.
Wiggermann P; Zuber-Jerger I; Zausig Y; Loss M; Scherer MN; Schreyer AG; Stroszczynski C; Jung EM
Clin Hemorheol Microcirc; 2011; 49(1-4):43-54. PubMed ID: 22214677
[TBL] [Abstract][Full Text] [Related]
8. Use of intra-procedural fusion imaging combining contrast-enhanced ultrasound using a perflubutane-based contrast agent and auto sweep three-dimensional ultrasound for guiding radiofrequency ablation and evaluating its efficacy in patients with hepatocellular carcinoma.
Sanga K; Numata K; Nihonmatsu H; Ogushi K; Fukuda H; Chuma M; Hashimoto H; Koizumi N; Maeda S
Int J Hyperthermia; 2020; 37(1):202-211. PubMed ID: 32070164
[No Abstract] [Full Text] [Related]
9. Fusion imaging of contrast-enhanced ultrasound and contrast-enhanced CT or MRI before radiofrequency ablation for liver cancers.
Bo XW; Xu HX; Wang D; Guo LH; Sun LP; Li XL; Zhao CK; He YP; Liu BJ; Li DD; Zhang K
Br J Radiol; 2016 Nov; 89(1067):20160379. PubMed ID: 27626506
[TBL] [Abstract][Full Text] [Related]
10. The Role of Contrast-enhanced Ultrasound in Guiding Radiofrequency Ablation of Hepatocellular Carcinoma: A Retrospective Study.
Chan AK; Hegarty C; Klass D; Yoshida E; Chung S; Liu DM; Ho SG; Harris AC
Can Assoc Radiol J; 2015 May; 66(2):171-8. PubMed ID: 25637354
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the ablation margin of hepatocellular carcinoma using CEUS-CT/MR image fusion in a phantom model and in patients.
Li K; Su Z; Xu E; Huang Q; Zeng Q; Zheng R
BMC Cancer; 2017 Jan; 17(1):61. PubMed ID: 28103837
[TBL] [Abstract][Full Text] [Related]
12. Utility of contrast-enhanced ultrasonography with Sonazoid in radiofrequency ablation for hepatocellular carcinoma.
Masuzaki R; Shiina S; Tateishi R; Yoshida H; Goto E; Sugioka Y; Kondo Y; Goto T; Ikeda H; Omata M; Koike K
J Gastroenterol Hepatol; 2011 Apr; 26(4):759-64. PubMed ID: 21054516
[TBL] [Abstract][Full Text] [Related]
13. Usefulness of contrast-enhanced ultrasonography with abdominal virtual ultrasonography in assessing therapeutic response in hepatocellular carcinoma treated with radiofrequency ablation.
Kisaka Y; Hirooka M; Kumagi T; Uehara T; Hiasa Y; Kumano S; Tanaka H; Michitaka K; Horiike N; Mochizuki T; Onji M
Liver Int; 2006 Dec; 26(10):1241-7. PubMed ID: 17105590
[TBL] [Abstract][Full Text] [Related]
14. Fusion imaging with contrast-enhanced ultrasonography for evaluating the early therapeutic efficacy of radiofrequency ablation for small hypervascular hepatocellular carcinomas with iso-echoic or unclear margins on conventional ultrasonography.
Nishigori S; Numata K; Irie K; Fukuda H; Chuma M; Maeda S
J Med Ultrason (2001); 2018 Jul; 45(3):405-415. PubMed ID: 29362966
[TBL] [Abstract][Full Text] [Related]
15. Usefulness of contrast-enhanced ultrasonography to evaluate the post-treatment responses of radiofrequency ablation for hepatocellular carcinoma: comparison with dynamic CT.
Inoue T; Kudo M; Hatanaka K; Arizumi T; Takita M; Kitai S; Yada N; Hagiwara S; Minami Y; Sakurai T; Ueshima K; Nishida N
Oncology; 2013; 84 Suppl 1():51-7. PubMed ID: 23428859
[TBL] [Abstract][Full Text] [Related]
16. The use of contrast-enhanced ultrasonography in the selection of patients with hepatocellular carcinoma for radio frequency ablation therapy.
Chen MH; Wu W; Yang W; Dai Y; Gao W; Yin SS; Yan K
J Ultrasound Med; 2007 Aug; 26(8):1055-63. PubMed ID: 17646367
[TBL] [Abstract][Full Text] [Related]
17. Early evaluation of treatment response to transarterial chemoembolization in patients with advanced hepatocellular carcinoma: The role of dynamic three-dimensional contrast-enhanced ultrasound.
Cao J; Dong Y; Fan P; Mao F; Chen K; Chen R; Huang B; Cheng Y; Wang WP
Clin Hemorheol Microcirc; 2021; 78(4):365-377. PubMed ID: 33682701
[TBL] [Abstract][Full Text] [Related]
18. The role of contrast-enhanced ultrasound in planning treatment protocols for hepatocellular carcinoma before radiofrequency ablation.
Chen MH; Yang W; Yan K; Dai Y; Wu W; Fan ZH; Callstrom MR; Charboneau JW
Clin Radiol; 2007 Aug; 62(8):752-60. PubMed ID: 17604763
[TBL] [Abstract][Full Text] [Related]
19. Quantitative dynamic contrast-enhanced ultrasound to predict intrahepatic recurrence of hepatocellular carcinoma after radiofrequency ablation: a cohort study.
Han X; Dong J; Liu Z; Wu B; Tian Y; Tan H; Cheng W
Int J Hyperthermia; 2020; 37(1):1066-1073. PubMed ID: 32924654
[TBL] [Abstract][Full Text] [Related]
20. Laparoscopic Contrast-Enhanced Ultrasonography for Real Time Monitoring of Laparoscopic Radiofrequency Ablation for Hepatocellular Carcinoma: an Observational Pilot Study.
Bartoș A; Bartos D; Spârchez Z; Iancu I; Ciobanu L; Iancu C; Breazu C
J Gastrointestin Liver Dis; 2019 Dec; 28(4):457-462. PubMed ID: 31826072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]